Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rochester, NY
NPI
1801833850
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
7
Medicare group memberships
Hospitals
2
Hospital affiliations
224 Alexander St, Suite 200
Rochester, NY, 14607
Phone (585) 922-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
565 services
Medicare patients, 2024
311
Average age 68
Drug cost, 2024
$4.9M
8,963 prescriptions
Company payments, 2025
$20K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Seth S Charatz was code 99214 (office e&m - established), 277 times for 182 patients. In total Seth S Charatz billed 565 services in 11 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 277 | 182 | $68.27 | $19K |
| 95251 Test - Miscellaneous | Office | 85 | 57 | $25.66 | $2,181 |
| 99204 Office E&M - New | Office | 55 | 55 | $99.68 | $5,482 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 37 | 31 | $12.27 | $454 |
| 99232 Hospital E&M - Subsequent | Facility | 36 | 23 | $63.12 | $2,272 |
| 99213 Office E&M - Established | Office | 31 | 29 | $32.25 | $1,000 |
| 99223 Hospital E&M - Initial | Facility | 24 | 23 | $128.77 | $3,090 |
By year: 2022 $39K for 544 services; 2023 $40K for 605 services; 2024 $35K for 565 services.
Medicare prescription drug claims, 2024
In 2024, the drug Seth S Charatz prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,097 prescriptions and refills. In total Seth S Charatz wrote 8,963 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,097 | 1,579 | 232 | $1.5M |
| Levothyroxine Sodium Generic | 826 | 2,111 | 242 | $11K |
| Jardiance Empagliflozin | 610 | 1,003 | 134 | $550K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 545 | 1,189 | 189 | $85K |
| Farxiga Dapagliflozin Propanediol | 470 | 652 | 90 | $361K |
| Metformin Hcl Er Metformin Hcl | 359 | 873 | 111 | $5,290 |
| Mounjaro Tirzepatide | 296 | 353 | 60 | $365K |
| Atorvastatin Calcium Generic | 283 | 715 | 87 | $3,897 |
| Metformin Hcl Generic | 265 | 658 | 81 | $2,485 |
| Methimazole Generic | 264 | 616 | 73 | $3,004 |
| Trulicity Dulaglutide | 252 | 326 | 64 | $314K |
| Glimepiride Generic | 244 | 579 | 72 | $3,412 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 229 | 521 | 86 | $19K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 223 | 409 | 85 | $66K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 173 | 326 | 54 | $75K |
Brand drugs: 5,294 claims; generic drugs: 3,022 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Seth S Charatz $20K ($20K in general payments such as food, travel and fees) from 4 companies. The largest payer was Novo Nordisk Inc with $20K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.